Cargando…
Expression and purification optimization of an N-terminal Pfs230 transmission-blocking vaccine candidate
In an effort to control and eventually eliminate malaria, the development of transmission-blocking vaccines has long been sought. However, few antigens have been evaluated in clinical trials, often due to limitations in the expression and purification of the antigen in sufficient yield and quality....
Autores principales: | Lee, Shwu-Maan, Plieskatt, Jordan, Krishnan, Seetha, Raina, Monika, Harishchandra, Rakeshkumar, King, C. Richter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547048/ https://www.ncbi.nlm.nih.gov/pubmed/30978392 http://dx.doi.org/10.1016/j.pep.2019.04.001 |
Ejemplares similares
-
The Pfs230 N-terminal fragment, Pfs230D1+: expression and characterization of a potential malaria transmission-blocking vaccine candidate
por: Lee, Shwu-Maan, et al.
Publicado: (2019) -
N-Terminal Pfs230 Domain Produced in Baculovirus as a Biological Active Transmission-Blocking Vaccine Candidate
por: Lee, Shwu-Maan, et al.
Publicado: (2017) -
Disulfide bond mapping of Pfs25, a recombinant malaria transmission blocking vaccine candidate
por: Lee, Shwu-Maan, et al.
Publicado: (2018) -
Development and Qualification of an Antigen Integrity Assay for a Plasmodium falciparum Malaria Transmission Blocking Vaccine Candidate, Pfs230
por: Miura, Kazutoyo, et al.
Publicado: (2022) -
A C-terminal Pfs48/45 malaria transmission-blocking vaccine candidate produced in the baculovirus expression system
por: Lee, Shwu-Maan, et al.
Publicado: (2020)